| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 9.227 | 11.215 | 10.920 | 8.137 | 5.910 |
| Total Income - EUR | - | - | - | - | - | 9.227 | 11.215 | 10.920 | 8.137 | 5.910 |
| Total Expenses - EUR | - | - | - | - | - | 7.164 | 10.566 | 9.471 | 6.628 | 5.743 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 2.063 | 650 | 1.449 | 1.509 | 167 |
| Net Profit/Loss - EUR | - | - | - | - | - | 1.786 | 313 | 1.121 | 1.198 | 88 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Zagrean Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 1.928 | 2.160 | 3.259 | 4.415 | 2.436 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 404 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | 52 | 0 |
| Cash | - | - | - | - | - | 1.928 | 2.160 | 3.259 | 3.959 | 2.436 |
| Shareholders Funds | - | - | - | - | - | 1.827 | 2.100 | 3.227 | 4.415 | 457 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 101 | 61 | 32 | 0 | 1.978 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Zagrean Med S.r.l.